Le Lézard
Classified in: Health
Subjects: SVY, TRI

New, Fast-Acting, Conservative Treatment Reverses Scoliosis


NEW YORK, April 3, 2024 /PRNewswire/ -- Nine million Americans have scoliosis; 90% of which presents during adolescence. A new clinical trial* demonstrates the efficacy of a unique, non-surgical treatment that quickly reduces curves that can become disabling. Lengthy, uncomfortable bracing and major spinal surgery (36,000 operations annually) can almost always be avoided with this new promising, anatomically-based, non-surgical approach that is a budding trend. Loren Fishman, MD, affiliated with Columbia University Medical School and medical director of Manhattan Physical Medicine and Rehabilitation, is the lead investigator of a ground-breaking clinical trial.

In a controlled, randomized study of 24 patients, aged 12-20 years old, yoga plus small injections of botulinum toxin during one office visit successfully reduced spinal curves an average of 10 degrees in three weeks and 15 degrees in three months. Progress continued after the initial three-months. One fairly easy physical yoga-like maneuver, done briefly three times a day, was shown in earlier published research** to significantly reduce lumbar curves. That foundational research demonstrated that the physical maneuver strengthened the weak spinal muscles on the convex side, swiftly reducing the curve. 

In this new study, in addition to the physical maneuver strengthening the weak muscles, botulinum toxin relaxes the tight muscles on the concave side of the spine. Together, this physical maneuver plus botulinum toxin works significantly more effectively than the yoga-like maneuver alone to reverse scoliosis.

Until now, embarrassing and difficult bracing and surgery have been the main treatments for 25-45 degree spinal curves. This new, successful muscle-balancing technique, offers hope to those who are handicapped by scoliosis.

Dr. Fishman and a study participant are available for interview.            

* https://www.mdpi.com/2813-0413/3/1/4, includes 1-minute explanatory video by lead investigator Loren Fishman, MD

** https://journals.sagepub.com/doi/10.1177/2164956120988259

Contact:
Carol Ardman
Manhattan Physical Medicine and Rehabilitation
[email protected]
Mobile: 917-856-6402

SOURCE Manhattan Physical Medicine and Rehabilitation


These press releases may also interest you

at 01:30
PARIS, FRANCE, 2 May 2024 - Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven biopharmaceutical company, announced today the appointment of Keira Driansky as EVP, President of North America, effective May 13, 2024. She will serve on the...

at 01:00
Management Report1 Q1 2024 highlights Strong performance in Perfumery & Beauty on good demand developmentGood performance in Taste, Texture & Health underpinned by market recoveryHealth, Nutrition & Care was soft, with improving momentum by end of...

at 00:01
Today, the Conference on Jewish Material Claims Against Germany (Claims Conference) launched a new digital campaign, #CancelHate. The campaign features Holocaust survivors reading Holocaust denial posts from across social media platforms. Each post...

at 00:00
With over four decades of nursing experience under her belt, Sherry Shaffer Ratajczak has witnessed firsthand the dedication of her colleagues in patient care. Yet, she observed a common misunderstanding: many are unaware of the extensive knowledge...

1 mai 2024
Today, a decision was issued by the Court of Appeals Division I in the State of Washington in Erickson v. Monsanto, ruling in Monsanto's favor on multiple grounds. This decision reverses the initial verdict of $185 million in its entirety and...

1 mai 2024
Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") and Poseida Therapeutics, Inc.  today announced that Xyphos Biosciences, Inc., (a wholly owned subsidiary of Astellas, "Xyphos") and Poseida have entered into a...



News published on and distributed by: